Nymox Pharmaceutical
NYMX
#9964
Rank
A$29.02 M
Marketcap
Country
$0.32
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.35 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$10.38 Million, an increase over its 2021 earnings that were of -A$19.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.35 Million-67.76%
2022 -A$10.38 Million-47.71%
2021 -A$19.85 Million6.61%
2020 -A$18.62 Million-10.91%
2019 -A$20.9 Million24.24%
2018 -A$16.82 Million-20.03%
2017 -A$21.03 Million2.71%
2016 -A$20.48 Million-63.86%
2015 -A$56.66 Million674.44%
2014 -A$7.32 Million-6.11%
2013 -A$7.8 Million-35.66%
2012 -A$12.12 Million-20.76%
2011 -A$15.29 Million38.33%
2010 -A$11.05 Million35.59%
2009 -A$8.15 Million11.8%
2008 -A$7.29 Million-12.94%
2007 -A$8.38 Million8.85%
2006 -A$7.7 Million36.5%
2005 -A$5.64 Million-4.4%
2004 -A$5.9 Million-14.58%
2003 -A$6.91 Million
2001 -A$5.07 Million-20.54%
2000 -A$6.38 Million21.72%
1999 -A$5.24 Million-25.56%
1998 -A$7.04 Million101.3%
1997 -A$3.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$11.15 B-324,625.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.66 B-514,352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.86 B-54,472.98%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.16 B-586,883.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.73 B-807,226.33%๐Ÿ‡บ๐Ÿ‡ธ USA